ResearcherHunan UniversityActive in the last 2 years

Weihong Tan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8066-1524; OpenAlex author ID A5024421064. Sources: OpenAlex.

Their work

Papers: 3 (first author 0, last author 3)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 4

Papers, trials and grants by year

2015: 2 papers · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 3

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yu Xiao · 1 shared paper, 2024 · strength 0.19
- Paper Aptamer-drug conjugates-loaded bacteria for pancreatic cancer synergistic therapy. DOI 10.1038/s41392-024-01973-3 ↗
Carole Champanhac · 2 shared papers, 2015 · strength 0.10
- Paper Development of a panel of DNA Aptamers with High Affinity for Pancreatic Ductal Adenocarcinoma. DOI 10.1038/srep16788 ↗
- Paper DNA Aptamer Selected against Pancreatic Ductal Adenocarcinoma for in vivo Imaging and Clinical Tissue Recognition. DOI 10.7150/thno.11938 ↗
Xiaoqiu Wu · 2 shared papers, 2015 · strength 0.10
- Paper Development of a panel of DNA Aptamers with High Affinity for Pancreatic Ductal Adenocarcinoma. DOI 10.1038/srep16788 ↗
- Paper DNA Aptamer Selected against Pancreatic Ductal Adenocarcinoma for in vivo Imaging and Clinical Tissue Recognition. DOI 10.7150/thno.11938 ↗
Mao Ye · 1 shared paper, 2015 · strength 0.05
- Paper DNA Aptamer Selected against Pancreatic Ductal Adenocarcinoma for in vivo Imaging and Clinical Tissue Recognition. DOI 10.7150/thno.11938 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.